Выбор темы
Выбор стиля шрифта
AbbVie новости
04/08
Квартальный отчет (10-Q) - AbbVie Inc.
26/05
ABBV - Сделка Инсайдера: продажа 23 мая 2022
19/05
ABBV - Сделка Инсайдера: продажа 16 мая 2022
19/05
ABBV - Сделка Инсайдера: продажа 17 мая 2022
11/05
ABBV - Сделка Инсайдера: продажа 10 мая 2022
26/03
ABBV - Сделка Инсайдера: продажа 24 марта 2022
12/03
ABBV - Сделка Инсайдера: продажа 09 марта 2022
03/03
ABBV - Сделка Инсайдера: продажа 01 марта 2022
09/02
ABBV - Сделка Инсайдера: продажа 07 февраля 2022
02/02
🔗
Invezz: AbbVie tops fourth-quarter estimates by 3%
02/02
🔗
Seeking Alpha: AbbVie Inc. (ABBV) CEO Rick Gonzalez on Q4 2021 Results - Earnings Call Transcript
02/02
🔗
Zacks Investment Research: AbbVie's (ABBV) Q4 Earnings Surpass Estimates, Sales Miss
02/02
🔗
CNBC: Cramer's Investing Club: We're encouraged AbbVie shares held recent gains after a mixed quarter
02/02
🔗
MarketBeat: High-Yield, Deep-Value AbbVie Confirms Uptrend
02/02
🔗
Zacks Investment Research: AbbVie (ABBV) Tops Q4 Earnings Estimates
02/02
🔗
Benzinga: AbbVie Expects Solid FY22 As Botox, Skyrizi Power Q4 Earnings
02/02
🔗
Market Watch: AbbVie's stock gains on fourth-quarter earnings as it reports better-than-expected sales of Humana
02/02
🔗
Reuters: AbbVie forecasts 2022 profit above estimates on strong sales of Botox, Skyrizi
01/02
🔗
The Motley Fool: Is AbbVie Stock a Buy Now?
01/02
🔗
Zacks Investment Research: Pharma Stocks to Report Q4 Earnings on Feb 2: ABBV, NVS & NVO
01/02
🔗
Zacks Investment Research: Why AbbVie (ABBV) Might Surprise This Earnings Season
01/02
🔗
Seeking Alpha: AbbVie Can Continue Generating Substantial Shareholder Returns
01/02
🔗
GuruFocus: Analysts Think Sales of AbbVie's Migraine Drugs Will Each Top $2 Billion
31/01
🔗
Zacks Investment Research: AbbVie's (ABBV) Q4 Earnings May Reflect Slower Sales Recovery
31/01
🔗
Seeking Alpha: 'Blue Chip' You Cannot Afford To Miss, Yield 4.1%: AbbVie
29/01
🔗
Invezz: Mizuho's Vamil Divan reveals his top biotech pick
29/01
🔗
Zacks Investment Research: Value, Growth, or Momentum: What Kind of Investor are You?
28/01
🔗
Zacks Investment Research: Is a Beat Likely for AbbVie (ABBV) This Earnings Season?
28/01
🔗
CNBC Television: Pete's latest options plays
27/01
🔗
Zacks Investment Research: 2 Stocks to Buy During Market Turbulence Before Earnings
27/01
🔗
Zacks Investment Research: Should Value Investors Pick AbbVie (ABBV) At Present?
27/01
🔗
Seeking Alpha: LABU - A Compelling Biotech Trade
26/01
🔗
The Motley Fool: 2 Reasons to Buy AbbVie Stock, and 1 Reason to Sell
25/01
🔗
Seeking Alpha: AbbVie: Skyrizi And Rinvoq Latest FDA Approvals Bode Well For Humira Patent Loss
25/01
🔗
Seeking Alpha: Vertex Investors Look Out...AbbVie Data In Cystic Fibrosis Coming Soon
25/01
🔗
Zacks Investment Research: AbbVie (ABBV) Gains But Lags Market: What You Should Know
24/01
🔗
Zacks Investment Research: AbbVie's (ABBV) Skyrizi Gets FDA Nod for Psoriatic Arthritis
24/01
🔗
The Motley Fool: 3 No-Brainer Healthcare Stocks to Buy Right Now for Less than $150
24/01
🔗
The Motley Fool: These High-Yield Dividend Stocks Are Growing at Blazing Speeds
23/01
🔗
The Motley Fool: Is AbbVie Stock a Top Pick for 2022?
22/01
🔗
The Motley Fool: 1 Top Dividend Stock to Buy Right Now
21/01
🔗
Stockmarketcom: Top Biotech Stocks To Buy Now? 5 For Your Late January Watchlist
20/01
🔗
Zacks Investment Research: 3 Value Stocks Breaking out in 2022
20/01
🔗
InvestorPlace: 3 Dividend Aristocrats Yielding Over 4%
19/01
🔗
InvestorPlace: 3 Dividend Stocks to Buy and Hold Forever
18/01
🔗
Benzinga: FDA Gives Back To Back Approval To Pfizer's & AbbVie's JAK Inhibitors For Atopic Dermatitis
18/01
🔗
Benzinga: FDA Approves AbbVie's Upadacitinib For Refractory Atopic Dermatitis In Patients 12 Years & Older
18/01
🔗
Zacks Investment Research: AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know
17/01
🔗
Zacks Investment Research: AbbVie's (ABBV) Rinvoq Gets FDA Nod for Atopic Dermatitis
17/01
🔗
Zacks Investment Research: 4 Large-Cap Drugmaker Stocks to Watch Despite Omicron Woes
17/01
🔗
The Motley Fool: Is AbbVie a Good Dividend Stock to Buy Right Now?
15/01
🔗
Seeking Alpha: AbbVie Will Keep Going Higher
12/01
🔗
Seeking Alpha: AbbVie Inc. (ABBV) Management Presents at JPMorgan 40th Annual Healthcare Conference (Transcript)
11/01
🔗
Seeking Alpha: AbbVie: Does Record Price Change Our Bull Thesis? No According To Buffett's Rule
10/01
🔗
Zacks Investment Research: AbbVie (ABBV) Seeks Rinvoq Nod for Non-Radiographic AS
07/01
🔗
Schaeffers Research: The Worst Stock to Buy This January
06/01
🔗
Zacks Investment Research: 4 Reasons Why You Should Add AbbVie (ABBV) to Your Portfolio
06/01
🔗
Seeking Alpha: AbbVie: Doing The RIG(HT) Thing
05/01
🔗
Zacks Investment Research: AbbVie (ABBV) is an Incredible Growth Stock: 3 Reasons Why
05/01
🔗
Zacks Investment Research: AbbVie (ABBV) Gets FDA Breakthrough Tag for Lung Cancer Drug
04/01
🔗
The Motley Fool: This Big Pharma Stock Is Enriching Shareholders With Its Dividend. But Is It a Buy?
04/01
🔗
Zacks Investment Research: AbbVie (ABBV) Gains But Lags Market: What You Should Know
03/01
🔗
Seeking Alpha: The Best Dividend Stocks For January 2022
02/01
🔗
The Motley Fool: Could This FDA Approval Create a Blockbuster Drug for AbbVie?
30/12
🔗
InvestorPlace: Best Stocks for 2022: Why AbbVie Looks Like High Dividend Growth Stock
29/12
🔗
Seeking Alpha: AbbVie: 2 Ways Buffett's Favorite High-Yield Dividend Aristocrat Can Help You Retire Rich
26/12
🔗
Stockmarketcom: Best Dividend Stocks To Buy In 2022? 5 For Your Watchlist
23/12
🔗
Seeking Alpha: AbbVie's Merry Christmas All Around
22/12
🔗
InvestorPlace: 3 of the Best Biotech Stocks for 2022 to Buy Now
18/12
ABBV - Сделка Инсайдера: продажа 15 декабря 2021
17/12
🔗
Stockmarketcom: 5 Biotech Stocks For Your Late December 2021 Watchlist
16/12
🔗
Pulse2: AbbVie Stock (ABBV): Why The Price Increased
15/12
🔗
Zacks Investment Research: AbbVie (ABBV) Rinvoq Gets FDA Nod for Active Psoriatic Arthritis
15/12
ABBV - Сделка Инсайдера: продажа 13 декабря 2021
14/12
🔗
The Motley Fool: 2 Warren Buffett Dividend Stocks to Buy Right Now
13/12
🔗
Zacks Investment Research: SpringWorks (SWTX) & AbbVie Unite for Multiple Myeloma Drug
11/12
🔗
The Motley Fool: 3 Best Dividend Stocks That Wall Street Is Sleeping On
11/12
ABBV - Сделка Инсайдера: продажа 09 декабря 2021
10/12
🔗
Pulse2: AbbVie Stock (ABBV): $165 Price Target From Wells Fargo
09/12
🔗
Invezz: Wells Fargo sees a 35% upside in this pharma stock
09/12
ABBV - Сделка Инсайдера: продажа 06 декабря 2021
08/12
🔗
Reuters: AbbVie settles New York opioid case for $200 million as trial winds down
07/12
🔗
Zacks Investment Research: AbbVie's (ABBV) Rinvoq Meets Goals in Crohn's Disease Study
06/12
🔗
Benzinga: AbbVie's Upadacitinib Hits Primary Goal In Induction Study In Patients With Crohn's Disease
06/12
🔗
Stockmarketcom: 5 Biotech Stocks To Watch In The Stock Market Today
02/12
🔗
Seeking Alpha: AbbVie Inc. (ABBV) Presents at 4th Annual Evercore ISI Virtual HealthCONx Conference (Transcript)
02/12
🔗
Market Watch: Financial Crime: ‘Brazen is probably an understatement': Georgia inmate ran multi-million dollar scam from prison cell posing as AbbVie employee
01/12
🔗
Zacks Investment Research: AbbVie (ABBV) Files for Skyrizi to Treat Crohn's Disease in EU
28/11
🔗
Seeking Alpha: AbbVie: A High-Yielder That Can Flood You With Cash
29/10
МНЕНИЕ: Конструктивные ожидания по AbbVie подтверждаются после отчетности - Финам
14/09
МНЕНИЕ: AbbVie недооценена и перспективна - Финам
11/05
Abbvie показала уверенный рост продаж в 1 квартале - Финам
Загрузить еще